Evaluation of Vascular Function, Effects of Exercise Training and Angiotensin Receptor II Antagonist in Patients With Type II Diabetes and Hypertension by Using Near-infrared Spectroscopy, Rapid Laser Doppler Blood Flow Imaging and Circulating Biomarkers.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2012
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- 29 Jan 2010 New trial record